Form 4: BeiGene CEO Sells Shares

Sentiment:

Insider Transaction (Form 4)


John Oyler, Chief Executive Officer and a Director of BeiGene, Ltd., sold 109,713 shares of common stock on July 20, 2026.

Summary

  • Open-market sale: disposed of 5,146 American Depositary Shares at $310.08 ($1,595,678) on July 20, 2026; holds 9,180 after (Direct).
  • Open-market sale: disposed of 6,273 American Depositary Shares at $310.75 ($1,949,310) on July 20, 2026; holds 2,907 after (Direct).
  • Open-market sale: disposed of 2,907 American Depositary Shares at $311.80 ($906,389) on July 20, 2026 (Direct).
  • Option exercise/conversion: acquired 33,990 American Depositary Shares at $119.96 ($4,077,440) on July 20, 2026; holds 33,990 after (Direct).
  • Open-market sale: disposed of 15,499 American Depositary Shares at $312.29 ($4,840,115) on July 20, 2026; holds 18,491 after (Direct).
  • Open-market sale: disposed of 14,326 American Depositary Shares at $312.96 ($4,483,433) on July 20, 2026; holds 4,165 after (Direct).
  • Open-market sale: disposed of 1,850 American Depositary Shares at $313.91 ($580,732) on July 20, 2026; holds 2,315 after (Direct).
  • Open-market sale: disposed of 1,512 American Depositary Shares at $315.26 ($476,678) on July 20, 2026; holds 803 after (Direct).
  • Open-market sale: disposed of 523 American Depositary Shares at $316.14 ($165,339) on July 20, 2026; holds 280 after (Direct).
  • Open-market sale: disposed of 280 American Depositary Shares at $318.30 ($89,124) on July 20, 2026 (Direct).
  • Open-market sale: disposed of 15,379 American Depositary Shares at $316.26 ($4,863,766) on July 21, 2026; holds 46,018 after (Direct).
  • Open-market sale: disposed of 20,029 American Depositary Shares at $316.91 ($6,347,340) on July 21, 2026; holds 25,989 after (Direct).
  • Open-market sale: disposed of 7,842 American Depositary Shares at $318.41 ($2,496,997) on July 21, 2026; holds 18,147 after (Direct).
  • Open-market sale: disposed of 15,807 American Depositary Shares at $319.29 ($5,047,019) on July 21, 2026; holds 2,340 after (Direct).
  • Open-market sale: disposed of 2,340 American Depositary Shares at $320.06 ($748,936) on July 21, 2026 (Direct).
  • Option exercise/conversion: disposed of 441,870 Share Option (Right to Buy) on July 20, 2026 (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $34,590,855 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

John Oyler — Director, Officer (Chief Executive Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-07-20Open-market saleAmerican Depositary Shares5,146$310$1.6M9,180
2026-07-20Open-market saleAmerican Depositary Shares6,273$311$1.9M2,907
2026-07-20Open-market saleAmerican Depositary Shares2,907$312$906.4K0
2026-07-20Option exercise/conversionAmerican Depositary Shares33,990$120$4.1M33,990
2026-07-20Open-market saleAmerican Depositary Shares15,499$312$4.8M18,491
2026-07-20Open-market saleAmerican Depositary Shares14,326$313$4.5M4,165
2026-07-20Open-market saleAmerican Depositary Shares1,850$314$580.7K2,315
2026-07-20Open-market saleAmerican Depositary Shares1,512$315$476.7K803
2026-07-20Open-market saleAmerican Depositary Shares523$316$165.3K280
2026-07-20Open-market saleAmerican Depositary Shares280$318$89.1K0
2026-07-21Open-market saleAmerican Depositary Shares15,379$316$4.9M46,018
2026-07-21Open-market saleAmerican Depositary Shares20,029$317$6.3M25,989
2026-07-21Open-market saleAmerican Depositary Shares7,842$318$2.5M18,147
2026-07-21Open-market saleAmerican Depositary Shares15,807$319$5.0M2,340
2026-07-21Open-market saleAmerican Depositary Shares2,340$320$748.9K0
2026-07-20Option exercise/conversionShare Option (Right to Buy)441,870——0

Key Dates

DateDescription
2026-07-20Open-market sale (5,146 shares)
2026-07-20Open-market sale (6,273 shares)
2026-07-20Open-market sale (2,907 shares)
2026-07-20Option exercise/conversion (33,990 shares)
2026-07-20Open-market sale (15,499 shares)
2026-07-20Open-market sale (14,326 shares)
2026-07-20Open-market sale (1,850 shares)
2026-07-20Open-market sale (1,512 shares)
2026-07-20Open-market sale (523 shares)
2026-07-20Open-market sale (280 shares)
2026-07-21Open-market sale (15,379 shares)
2026-07-21Open-market sale (20,029 shares)
2026-07-21Open-market sale (7,842 shares)
2026-07-21Open-market sale (15,807 shares)
2026-07-21Open-market sale (2,340 shares)
2026-07-20Option exercise/conversion (441,870 shares)

Keywords

insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, John Oyler

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.